Positive Phase III results with Avastin in breast cancer patients

被引：0
|
作者：
不详
机构：
来源：
IMMUNOTHERAPY | 2009年 / 1卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [31] Letter to the editor on 'Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial'
    Barry, P. A.
    Schiavon, G.
    MacNeill, F. A.
    ANNALS OF ONCOLOGY, 2014, 25 (04) : 909 - 910
  • [32] Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study
    Jackisch, C.
    Kim, S. -B.
    Semiglazov, V.
    Melichar, B.
    Pivot, X.
    Hillenbach, C.
    Stroyakovskiy, D.
    Lum, B. L.
    Elliott, R.
    Weber, H. A.
    Ismael, G.
    ANNALS OF ONCOLOGY, 2015, 26 (02) : 320 - 325
  • [33] Positive Top-line Results from the Phase III Breast Cancer Study PALOMA-2 for the CDK 4/6 Inhibitor Palbociclib
    Janik, Achim
    BREAST CARE, 2016, 11 (03) : 227 - 227
  • [34] Positive results achieved from Phase III trials of Iluvien (R) in patients with diabetic macular edema
    不详
    EXPERT REVIEW OF OPHTHALMOLOGY, 2010, 5 (01) : 9 - 9
  • [35] EFFICACY OF INTRANASAL FENTANYL FOR BREAKTHROUGH PAIN IN PATIENTS WITH CANCER: RESULTS OF A PHASE III TRIAL
    Nolte, T.
    Marchesini, C.
    Oronska, A.
    Kaczmarek, Z.
    Kaasa, S.
    Kress, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 254 - 254
  • [36] Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy in stage II and III breast cancer patients:: Preliminary results of a phase II and pharmacogenomic study
    Estévez, LG
    Sánchez-Rovira, P
    Dómine, M
    León, A
    Calvo, I
    Jaén, A
    Casado, V
    Rubio, G
    Díaz, M
    Miró, C
    Lobo, F
    SEMINARS IN ONCOLOGY, 2004, 31 (02) : 31 - 36
  • [37] Translating the results of phase III randomized cancer trials into the language of physician obligation to patients
    Maurie Markman
    Current Oncology Reports, 2004, 6 (4) : 243 - 244
  • [38] Zinc-L-carnosine prevented dysphagia in breast cancer patients undergoing adjuvant radiotherapy: Results of a phase III randomized trial
    Saldi, Simonetta
    Perrucci, Elisabetta
    Fulcheri, Christian Paolo Luca
    Mariucci, Cristina
    Chierchini, Sara
    Ingrosso, Gianluca
    Falcinelli, Lorenzo
    Podlesko, Anna Maria
    Merluzzi, Mara
    Bini, Vittorio
    Aristei, Cynthia
    BREAST JOURNAL, 2020, 26 (09): : 1882 - 1884
  • [39] Results of a phase II trial of Herceptin® plus Xeloda® in patients with previously untreated HER2-positive metastatic breast cancer
    Xu, L
    Song, S
    Zhu, J
    Luo, R
    Lil, L
    Jiao, S
    Pan, H
    Tao, M
    Su, Y
    Liu, D
    Chen, L
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S128 - S129
  • [40] Current phase III breast cancer clinical trials
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (07): : 696 - +
12345